July 1 (Reuters) - Recce Pharmaceuticals Ltd (RCE) :
- RECCE PHARMACEUTICALS REPORTS POSITIVE DATA FROM PHASE I/II URINARY TRACT INFECTION (UTI) / UROSEPSIS RAPID INFUSION TRIAL OF RECCE® 327
- RECCE PHARMACEUTICALS LTD: NO SERIOUS ADVERSE EVENTS AND CLINICALLY SIGNIFICANT CHANGES OBSERVED, REINFORCING SAFETY PROFILE OF R327
- RECCE PHARMACEUTICALS LTD: ON TRACK TO INITIATE PHASE II TRIAL OF R327 IN PATIENTS WITH URINARY TRACT INFECTIONS IN H2 2024
- Forums
- ASX - By Stock
- RCE
- News: RCE Recce Pharmaceuticals Says No Serious Adverse Events And Clinically Significant Changes...
News: RCE Recce Pharmaceuticals Says No Serious Adverse Events And Clinically Significant Changes...
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $122.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 77741 | 62.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.0¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 77741 | 0.620 |
2 | 4139 | 0.610 |
1 | 4000 | 0.600 |
1 | 1800 | 0.550 |
3 | 111000 | 0.540 |
Price($) | Vol. | No. |
---|---|---|
0.590 | 10000 | 1 |
0.600 | 949 | 1 |
0.610 | 30000 | 1 |
0.635 | 4250 | 1 |
0.650 | 19073 | 6 |
Last trade - 16.16pm 01/07/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online